Insight Molecular Diagnostics Inc (IMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 257 | 101 | N/A |
| Marketable Securities | 3,280 | 4,630 | N/A |
| TOTAL | $3,651 | $4,851 | $N/A |
| Non-Current Assets | |||
| PPE Net | 118 | 148 | N/A |
| Intangibles | 1,472 | 1,714 | 0 |
| Other Non-Current Assets | 0 | 1,574 | 0 |
| TOTAL | $1,590 | $3,436 | $N/A |
| Total Assets | $5,241 | $8,287 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 6,033 | 3,066 | 0 |
| Accrued Expenses | 282 | 32 | N/A |
| TOTAL | $6,315 | $4,672 | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $6,315 | $4,672 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 15,147 | 15,398 | N/A |
| Retained earnings | -15,399 | -10,413 | N/A |
| Other shareholders' equity | -822 | -1,370 | 0 |
| TOTAL | $-1,074 | $3,615 | $N/A |
| Total Liabilities And Equity | $5,241 | $8,287 | $0 |